| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/23/2006 | EP1691759A2 Plant-derived protein extract compositions and methods |
| 08/23/2006 | EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/23/2006 | EP1691744A2 Methods and reagents for the treatment of inflammatory disorders |
| 08/23/2006 | EP1691743A2 Regulation of cell membrane-mediated effects |
| 08/23/2006 | EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 08/23/2006 | EP1691613A2 Disinfecting composition, preparation and use thereof |
| 08/23/2006 | EP1669357A8 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[ 2,3-d,6,5-d'] dipyrimidine and 10-aza-analogue thereof |
| 08/23/2006 | EP1633346B1 Pyrrolidin-1, 2- dicarboxylic acid- 1- (4- ethinyl- phenyl) - amid|- 2- (phenyl)- amid| derivative as inhibitors of coagulation factor xa and viia for the treatment of thrombosis |
| 08/23/2006 | EP1583524B1 Bis (thio-hydrazide amide) compounds for treating multi-drug resistant cancer |
| 08/23/2006 | EP1581480B1 Cyclopentyl-substituted glutaramide compounds as endopeptidase-v inhibitors |
| 08/23/2006 | EP1569607A4 Tough polymers |
| 08/23/2006 | EP1558612B1 Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same |
| 08/23/2006 | EP1539133B1 Aminocyclohexene quinolines and their azaisosteric analogues with antibacterial activity |
| 08/23/2006 | EP1534271B1 Antitumor compound and therapeutic uses thereof |
| 08/23/2006 | EP1490350B1 Pyranon and pyrandion inhibitors of hepatitis c virus rna-dependent rna polymerase |
| 08/23/2006 | EP1485391B1 Phosphate transport inhibitors |
| 08/23/2006 | EP1485084B9 Use of an l-ascorbic acid salt to prepare a pharmaceutical composition for ophthalmic topical use capable of improving the level of l-ascorbic acid in the eye |
| 08/23/2006 | EP1476426B1 Hydroxylated indirubin derivatives |
| 08/23/2006 | EP1441785A4 Improved method for generating an aerosol |
| 08/23/2006 | EP1432414B1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/23/2006 | EP1417205B1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases |
| 08/23/2006 | EP1404309B1 A pharmaceutical combination comprising either (s)-2-ethoxy-3- 4-(2- 4-methane sulfonyl oxyphenyl ethoxy) phenyl| propanoic acid or 3- 4- 2- (4-tert-butoxy carbonyl aminophenyl) ethoxy| phenyl -(s)-2-ethoxy propanoic acid and a biguanide drug |
| 08/23/2006 | EP1401836B1 Imidazo¬1,2-a|pyridine derivatives for the prophylaxis and treatment of herpes viral infections |
| 08/23/2006 | EP1401445B1 Crystalline anticholinergic, method for its production, and use thereof in the production of a drug |
| 08/23/2006 | EP1385528B1 Disinfecting and solubilizing steroid compositions |
| 08/23/2006 | EP1381364B1 Use of mangafodipir for treating hepatocellular insufficiency |
| 08/23/2006 | EP1368358B1 Isoxazoline derivatives as anti-depressants |
| 08/23/2006 | EP1363920B1 Modified psma ligands and uses related thereto |
| 08/23/2006 | EP1349855B1 5-'4-'2-(n-methyl-n- (2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione mesylate salt |
| 08/23/2006 | EP1345907B1 7-heterocyclyl quinoline and thieno 2,3-b|pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1337529B1 Heterocyclylalkyl piperidine derivatives, their preparation and compositions containing same |
| 08/23/2006 | EP1332144B1 Indole derivatives as pde5-inhibitors |
| 08/23/2006 | EP1329451B1 Spiro compounds and adhesion molecule inhibitors containing the same as the active ingredient |
| 08/23/2006 | EP1324981B1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 08/23/2006 | EP1278747B1 Pyrano, piperidino, and thiopyrano compounds and methods of use |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1272457B1 Compounds for modulating cell proliferation |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1223929B1 Cannabimimetic indole derivatives |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1198232B1 Urea substituted imidazoquinolines |
| 08/23/2006 | EP1190079B1 Control of gene expression in eukaryotic cells |
| 08/23/2006 | EP1189637B1 Compositions for improving bioavailability of orally administered drugs |
| 08/23/2006 | EP1165570B1 Novel phosphorus-containing prodrugs |
| 08/23/2006 | EP1146870B1 Antioxidant compositions for companion animals |
| 08/23/2006 | EP1126837B1 Fulvic acid and its use in the treatment of various conditions |
| 08/23/2006 | EP1078927B1 Carbapenem derivatives, utilization thereof and intermediate compounds of the same |
| 08/23/2006 | EP1052963B1 Use of alkanoic acid containing compositions for treating nail fungal conditions |
| 08/23/2006 | EP1051482B1 Cytotoxic heteromeric protein combinatorial libraries |
| 08/23/2006 | EP1051405B1 Novel dihydroxyhexanoic acid derivatives |
| 08/23/2006 | EP1027328B1 Substituted anilides |
| 08/23/2006 | EP1007566B1 Therapeutic use of the smr1 protein and active derivatives thereof |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0837052B1 Bicyclic amino derivatives and pgd 2 antagonist containing the same |
| 08/23/2006 | EP0833636B1 Method for inhibiting neoplastic disease in mammals |
| 08/23/2006 | EP0800514B1 Substituted imides as tnf inhibitors |
| 08/23/2006 | CN1823092A Therapy-enhancing glucan |
| 08/23/2006 | CN1823083A Lincomycin derivatives possessing antibacterial activity |
| 08/23/2006 | CN1823081A Rapamycin carbohydrate derivatives |
| 08/23/2006 | CN1823078A Process for controlling crystal structure of risedronate |
| 08/23/2006 | CN1823076A Silicon compounds and their use |
| 08/23/2006 | CN1823073A CCI-779 isomer C |
| 08/23/2006 | CN1823072A Inhibitors of P38 and methods of using the same |
| 08/23/2006 | CN1823071A Thienopyrimidine derivatives as potassium channel inhibitors |
| 08/23/2006 | CN1823070A Salinosporamides and methods for use thereof |
| 08/23/2006 | CN1823068A Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors |
| 08/23/2006 | CN1823067A Compounds having inhibitive activity of phosphatidylinositol 3-kinase and methods of use thereof |
| 08/23/2006 | CN1823066A Substituted tetrahydro-1h-pyrazolo [3,4-c]pyridines, compositions comprising them, and use |
| 08/23/2006 | CN1823064A 2-arylamino-pyrimidines for the treatment of GSK3-related disorders |
| 08/23/2006 | CN1823062A Sulfonyldihydro- benzimidazolone compounds as 5-hydroxytryptamine-6 ligands |
| 08/23/2006 | CN1823061A Pyrrole-2, 5-dione derivatives as liver X receptor modulators |
| 08/23/2006 | CN1823057A Biaryl piperazinyl-pyridine analogues |
| 08/23/2006 | CN1823056A Trisubstituted aryl and heteroaryl derivatives as modulatorsof metabolism and the prophylaxis and treatment of disorders related thereto |
| 08/23/2006 | CN1823054A Imidazole derivatives ó¾ |
| 08/23/2006 | CN1823048A Substituted pyrimidin-4-ylamina analogues as vanilloid receptor ligands |
| 08/23/2006 | CN1823046A Phenyl quinolines and their use as estrogenic agents |
| 08/23/2006 | CN1823043A Hydroxypyridine cgrp receptor antagonists |
| 08/23/2006 | CN1823041A 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 08/23/2006 | CN1823040A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| 08/23/2006 | CN1823039A Cyclic aminophenyl sulfamate derivative |
| 08/23/2006 | CN1823036A Novel dibenzo[B,F]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 08/23/2006 | CN1822880A Parasiticidal composition |
| 08/23/2006 | CN1822879A Use of whey permeate for the treatment of metabolic syndrome |
| 08/23/2006 | CN1822859A Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 08/23/2006 | CN1822858A Stable non-dihydrate azithromycin oral suspensions |
| 08/23/2006 | CN1822854A Methods and compositions for controlling ectoparasites |
| 08/23/2006 | CN1822848A Combinations of vasoactive agents and their use in the treatment of sexual dysfunctions |
| 08/23/2006 | CN1822847A Plant worms mycelium extracat fraction and composition for oral intake |
| 08/23/2006 | CN1822845A Means for preventing and treating cellular death and their biological applications |
| 08/23/2006 | CN1822844A Glycoside-containing liposome |
| 08/23/2006 | CN1822843A Process for preparing particles containing an antiviral |
| 08/23/2006 | CN1822842A Solid pharmaceutical preparation |
| 08/23/2006 | CN1822841A Anti-coronavirus drug |
| 08/23/2006 | CN1822840A Muscarinic acetylcholine receptor antagonists |
| 08/23/2006 | CN1822839A Muscarinic acetylcholine receptor antagonists |
| 08/23/2006 | CN1822838A Muscarinic acetylcholine receptor antagonists |
| 08/23/2006 | CN1822837A 2-methoxymethyl-3-(3,4-dichlorophenyl)-8-azabicyclo[3.2.1]octane tartrate salts |
| 08/23/2006 | CN1822836A Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor |